ABVC vs ACIU

ABVC Biopharma, Inc. vs AC Immune SA — Valuation Comparison 2026

ABVC

Biotechnology
ABVC Biopharma, Inc.
Quality
4.9
out of 10
Value Trap
24
SAFE
Price
$1.41
Last close
Models
8/13
Active
VS

ACIU

Biotechnology
AC Immune SA
Quality
4.5
out of 10
Value Trap
35
LOW
Price
$2.66
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType ABVC Fair ValueABVC Upside ACIU Fair ValueACIU Upside
Bayesian DCF Intrinsic $0.31 -78.3% $0.43 -84.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.02 -98.4% $0.09 -96.9%
Dynamic NAV Asset-Based $0.08 -94.4% $0.16 -94.5%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ABVC vs ACIU — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ABVC vs ACIU — Which Stock Is More Undervalued?

ABVC scores higher with a 4.9/10 quality rating vs ACIU's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ABVC Biopharma, Inc. (ABVC) and AC Immune SA (ACIU) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ABVC currently trades at $1.41 with a QOC of 4.9/10, while ACIU trades at $2.66 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).